In December 2012, the FDA approved Juxtapid (lomitapide) to reduce LDL-C, total cholesterol, apolipoprotein B, and non HDL-C in patients with HoFH.
FORBES: FDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia
英汉双解词典包含3185865条英汉词条，基本涵盖了全部常用单词的翻译及用法，是英语学习的有利工具。